TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Arctic Bioscience AS
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
22,377
|
24,211
|
16,042 |
| Financial expenses |
1,557
|
3
|
1,581 |
| Earnings before taxes |
-30,178
|
-24,036
|
-31,748 |
| Total assets |
199,077
|
231,503
|
254,606 |
| Current assets |
88,286
|
140,107
|
199,028 |
| Current liabilities |
26,287
|
28,556
|
15,599 |
| Equity capital |
171,432
|
202,947
|
239,007 |
| - share capital |
1,682
|
1,722
|
1,812 |
| Employees (average) | 17 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.1%
|
87.7%
|
93.9% |
| Turnover per employee | 1,424 | ||
| Profit as a percentage of turnover |
-134.9%
|
-99.3%
|
-197.9% |
| Return on assets (ROA) |
-14.4%
|
-10.4%
|
-11.8% |
| Current ratio |
335.9%
|
490.6%
|
1275.9% |
| Return on equity (ROE) |
-17.6%
|
-11.8%
|
-13.3% |
| Change turnover |
-346
|
9,012
|
759 |
| Change turnover % |
-2%
|
59% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.